Tundra Space

Tundra Space

Clinical Research Directory

Browse clinical research sites, groups, and studies.

Back to Studies
ACTIVE NOT RECRUITING
NCT05796752
PHASE2/PHASE3

Behavioral Treatment and Memantine in Body Focused Repetitive Behaviors

Sponsor: University of Chicago

View on ClinicalTrials.gov

Summary

The goal of the proposed study is to compare the efficacy of behavioral treatment (BT) to memantine, a psychopharmacological agent, for BFRBs. 28 subjects with trichotillomania (TTM) or skin picking disorder (SPD) will receive 8 weeks of memantine treatment, followed by 8 weeks of comprehensive behavioral therapy (ComB) treatment. The hypothesis to be tested is that behavioral therapy will be associated with superior clinical outcomes as compared to memantine. A second hypothesis is that both memantine and behavioral therapy will demonstrate improvement from baseline to the respective posttreatment assessment.

Official title: Single-Group Crossover Trial Comparing Behavioral Treatment to Memantine in Body Focused Repetitive Behaviors

Key Details

Gender

All

Age Range

18 Years - Any

Study Type

INTERVENTIONAL

Enrollment

26

Start Date

2023-08-02

Completion Date

2026-06

Last Updated

2025-12-03

Healthy Volunteers

No

Interventions

DRUG

Memantine

Cognition-enhancing medication

BEHAVIORAL

ComB Behavioral Therapy

Therapy for BFRBs

Locations (1)

University of Chicago Medical Center

Chicago, Illinois, United States